2022
DOI: 10.1016/j.lfs.2022.120984
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(8 citation statements)
references
References 294 publications
0
8
0
Order By: Relevance
“…Prostate, renal, and bladder cancer (BCa) are the most common tumors of the urinary system [ 1 ]. Urinary system tumors account for approximately 10% of total tumor incidence, with prostate cancer accounting for 29% of male cancer cases [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Prostate, renal, and bladder cancer (BCa) are the most common tumors of the urinary system [ 1 ]. Urinary system tumors account for approximately 10% of total tumor incidence, with prostate cancer accounting for 29% of male cancer cases [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Doxorubicin, an important component of combination therapy for muscle‐invasive BC, interferes with cell cycle progression and leads to cancer cell death 49 . Curcumin has a wide range of anticancer activities; it can inhibit the proliferation of BC cells, induce the apoptosis of BC cells, prevent the metastasis of BC cells, promote the antitumor immune response, and enhance the effect of chemotherapeutic drugs when used in combination with chemical drugs 50–52 . However, curcumin has the disadvantage of low bioavailability, and the development of curcumin nanoparticles may significantly improve this problem 53 .…”
Section: Discussionmentioning
confidence: 99%
“…49 Curcumin has a wide range of anticancer activities; it can inhibit the proliferation of BC cells, induce the apoptosis of BC cells, prevent the metastasis of BC cells, promote the antitumor immune response, and enhance the effect of chemotherapeutic drugs when used in combination with chemical drugs. [50][51][52] However, curcumin has the disadvantage of low bioavailability, and the development of curcumin nanoparticles may significantly improve this problem. 53 We found that the mRNA levels of CYP1B1 were reduced after curcumin treatment.…”
Section: F I G U R Ementioning
confidence: 99%
“…Xie et al [ 503 ] reported that curcumin together with photodynamic therapy have been confirmed as effective in many kinds of cancer cells in vitro and animal models. It has been extensively applied in cancer treatment because of its ability to trigger cell death and suppress metastasis [ 504 ]. Mahjoob and Stochaj [ 505 ] reported that curcumin improves aging-related cellular and organ dysfunctions.…”
Section: The Health Benefits Of Curcuminoids (Curcumin Demethoxycurcu...mentioning
confidence: 99%